Tumor‐Specific Peroxynitrite Overproduction Disrupts Metabolic Homeostasis for Sensitizing Melanoma Immunotherapy
Advanced Materials · 2023
DOI: 10.1002/adma.202301455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2023. Verfasst von Lijun Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Radiopharmacokinetics for Innovative Drugs Chinese Academy of Medical Sciences Tianjin Key Laboratory of Radiation Medicine and Mol…. Hauptthemen laut MEDLINE: Neoplasms, Melanoma. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: National Science Fund for Distinguished Young Scholars of China, National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Tumor cells elicit metabolic reprogramming to establish an immunosuppressive tumor microenvironment (TME) for escaping from immunosurveillance. Therefore, interrupting the metabolic adaptation of tumor cells may be a promising strategy for TME immunomodulation, favoring immunotherapy. In this work, a tumor‐specific peroxynitrite nanogenerator APAP‐P‐NO is constructed that can selectively disrupt metabolic homeostasis in melanoma cells. Stimulated by melanoma‐characteristic acid, glutathione, and tyrosinase, APAP‐P‐NO can efficiently generate peroxynitrite through the in situ coupling of the produced superoxide anion and released nitric oxide. Metabolomics profiling reveals that the accumulated peroxynitrite induces a great decrease in metabolites in the tricarboxylic acid cycle. Meanwhile, the glycolysis‐produced lactate drops sharply both intracellularly and extracellularly under peroxynitrite stress. Mechanistically, peroxynitrite impairs the activity of glyceraldehyde‐3‐phosphate dehydrogenase in glucose metabolism through S ‐nitrosylation. The metabolic alterations effectively reverse the immunosuppressive TME to evoke potent antitumor immune responses, including polarization of M2‐like macrophages to M1phenotype, reduction of myeloid‐derived suppressor cells and regulatory T cells, and restoration of CD8 + T cell infiltration. Combining APAP‐P‐NO with anti‐PD‐L1 achieves a significant inhibition against both primary and metastatic melanomas without systemic toxicities. Collectively, a tumor‐specific peroxynitrite overproduction approach is developed and the possible mechanism of peroxynitrite‐mediated TME immunomodulation is explored, providing a new strategy for facilitating immunotherapy sensitivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Radiopharmacokinetics for Innovative Drugs Chinese Academy of Medical Sciences Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine Institute of Radiation Medicine, Chinese Acade…
ORCID-Profile: Jinjian Liu, Jianfeng Liu
Förderung
- National Science Fund for Distinguished Young Scholars of China
- National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Sciences
- Science Foundation for Distinguished Young Scholars of Tianjin
- Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
Zitieren
APA
Yang, L., Wang, D., Jia, H., Yang, C., Zhang, Y., Li, H., Liu, J., & Liu, J. (2023). Tumor‐Specific Peroxynitrite Overproduction Disrupts Metabolic Homeostasis for Sensitizing Melanoma Immunotherapy. Advanced Materials. https://doi.org/10.1002/adma.202301455
Vancouver
Yang L, Wang D, Jia H, Yang C, Zhang Y, Li H, et al. Tumor‐Specific Peroxynitrite Overproduction Disrupts Metabolic Homeostasis for Sensitizing Melanoma Immunotherapy. Advanced Materials. 2023. doi:10.1002/adma.202301455
BibTeX
@article{Yang2023,
author = {Yang, Lijun and Wang, Dianyu and Jia, Haixue and Yang, Cuihong and Zhang, Yumin and Li, Hui and Liu, Jinjian and Liu, Jianfeng},
title = {Tumor‐Specific Peroxynitrite Overproduction Disrupts Metabolic Homeostasis for Sensitizing Melanoma Immunotherapy},
journal = {Advanced Materials},
year = {2023},
doi = {10.1002/adma.202301455}
}
EUVIMED